The E1B-55-kDa protein of adenovirus type 5 and the p53 tumor suppressor ge
ne product form a complex that localizes to the cytoplasm, thereby downregu
lating p53's transcriptional activity. The E4orf6 protein binds and relocal
izes E1B-55-kDa, and the proteins act synergistically to inactivate p53. We
show that another adenovirus E4 gene product, E4orf3, is also sufficient t
o relocalize E1B-55-kDa from the cytoplasm to the nucleus. Both proteins ar
e then found in discrete nuclear structures (tracks) that are known to cont
ain components of the promyelocytic leukemia-associated nuclear structure.
Simultaneously, p53 is dissociated from E1B-55-kDa and is found evenly dist
ributed over the nucleoplasm. In the presence of E4orf3, p53-dependent tran
scriptional activity is no longer repressed by E1B-55-kDa. When E1B-55-kDa
is coexpressed with E4orf3 and E4orf6, E1B-55-kDa is found to colocalize wi
th E4orf6 rather than E4orf3. In parallel, p53 is inhibited and degraded by
the combination of E1B-55-kDa and E4orf6, regardless of coexpressed E4orf3
. This suggests that the effects of E4orf6 on E1B-55-kDa overrule the actio
ns of E4orf3. When cells are infected with virus expressing E4orf3 but not
E4orf6, E1B is found in the cell nucleus and p53 enters the virus replicati
on centers. After infection with wild-type adenovirus, E4orf3 is expressed
before E4orf6 and E1B temporarily colocalizes with E4orf3 in nuclear tracks
before associating with E4orf6. We propose that during adenovirus infectio
n, the E4orf3 protein transiently liberates p53 from its association with E
1B-55-kDa. Subsequently, p53 is inactivated and degraded by the combination
of E1B-55-kDa and E4orf6.